Is LOBEF or RYLD a better dividend investment in 2026?

LOBEF currently yields 3861.00% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: LOBEF offers higher current income.

What is the dividend yield difference between LOBEF and RYLD?

LOBEF has a forward dividend yield of 3861.00% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 3848.86 percentage points.

Home › Compare › LOBEF vs RYLD

LOBEF vs RYLD: Dividend Comparison 2026

LOBEF yields 3861.00% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LOBEF wins by $5102776617539.96M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LOBEF

● Live price

3861.00%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5102776617540.00M

Annual income

$4,855,397,881,919,778,000.00

Full LOBEF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — LOBEF vs RYLD

📍 LOBEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LOBEF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LOBEF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LOBEF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LOBEF

Annual income on $10K today (after 15% tax)

$328,185.33/yr

After 10yr DRIP, annual income (after tax)

$4,127,088,199,631,811,000.00/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, LOBEF beats the other by $4,127,088,199,631,809,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LOBEF + RYLD for your $10,000?

LOBEF: 50%RYLD: 50%

100% RYLD50/50100% LOBEF

Portfolio after 10yr

$2551388308770.02M

Annual income

$2,427,698,940,959,890,400.00/yr

Blended yield

95.15%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LOBEF buys

RYLD buys

No recent congressional trades found for LOBEF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLOBEFRYLD

Forward yield	3861.00% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$5102776617540.00M ✓	$44.5K
Annual income after 10y	$4,855,397,881,919,778,000.00 ✓	$2,587.35
Total dividends collected	$5085877075297.57M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: LOBEF vs RYLD ($10,000, DRIP)

Year	LOBEF Portfolio	LOBEF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$396,800	$386,100.39	$11,914	$1,213.65	+$384.9K → LOBEF
2	$14,742,780	$14,318,203.95	$14,099	$1,351.30	+$14.73M → LOBEF
3	$512,952,973	$497,178,198.17	$16,580	$1,494.55	+$512.94M → LOBEF
4	$16,715,748,598	$16,166,888,916.48	$19,384	$1,642.61	+$16715.73M → LOBEF
5	$510,255,139,456	$492,369,288,456.53	$22,535	$1,794.70	+$510255.12M → LOBEF
6	$14,592,492,784,652	$14,046,519,785,434.00	$26,063	$1,950.00	+$14592492.76M → LOBEF
7	$391,042,310,644,499	$375,428,343,364,921.60	$29,995	$2,107.69	+$391042310.61M → LOBEF
8	$9,820,789,713,309,148	$9,402,374,440,919,534.00	$34,361	$2,266.99	+$9820789713.27M → LOBEF
9	$231,195,080,018,900,830	$220,686,835,025,660,030.00	$39,194	$2,427.12	+$231195080018.86M → LOBEF
10	$5,102,776,617,540,002,000	$4,855,397,881,919,778,000.00	$44,525	$2,587.35	+$5102776617539.96M → LOBEF

LOBEF vs RYLD: Complete Analysis 2026

LOBEF — Stock

Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

Full LOBEF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this LOBEF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LOBEF vs SCHD LOBEF vs JEPI LOBEF vs O LOBEF vs KO LOBEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.